Cargando…

Tongxinluo Improves Apolipoprotein E-Deficient Mouse Heart Function

BACKGROUND: Our previous studies have shown that Tongxinluo (TXL), a compound Chinese medicine, can decrease myocardial ischemia-reperfusion injury, protect capillary endothelium function, and lessen cardiac ventricle reconstitution in animal models. The aim of this study was to illuminate whether T...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yuan, Guo-Qiang, Gao, Song, Geng, Yong-Jian, Tang, Yao-Ping, Zheng, Min-Juan, Shelat, Harnath S, Collins, Scott, Wu, Han-Jing, Wu, Yi-Ling
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Medknow Publications & Media Pvt Ltd 2018
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5850670/ https://www.ncbi.nlm.nih.gov/pubmed/29483388 http://dx.doi.org/10.4103/0366-6999.226063

Ejemplares similares

Tongxinluo mitigates atherogenesis by regulating angiogenic factors and inhibiting vasa vasorum neovascularization in apolipoprotein E-deficient mice
por: Ma, Lianyue, et al.
Publicado: (2016)

Cardiac and vascular phenotypes in the apolipoprotein E-deficient mouse
por: Vasquez, Elisardo C, et al.
Publicado: (2012)

Tongxinluo Protects against Pressure Overload–Induced Heart Failure in Mice Involving VEGF/Akt/eNOS Pathway Activation
por: Wang, Bo, et al.
Publicado: (2014)

Apolipoprotein E Deficiency Causes Endothelial Dysfunction in the Mouse Retina
por: Zadeh, Jenia Kouchek, et al.
Publicado: (2019)

Correction: Tongxinluo protects against pressure overload-induced heart failure in mice involving VEGF/Akt/eNOS pathway activation
por: Wang, Bo, et al.
Publicado: (2019)

Hyperglycemia in apolipoprotein E-deficient mouse strains with different atherosclerosis susceptibility
por: Li, Jing, et al.
Publicado: (2011)

Tongxinluo Capsule Combined with Atorvastatin for Coronary Heart Disease: A Systematic Review and Meta-Analysis
por: Liu, Qiao, et al.
Publicado: (2021)

Isoliquiritigenin Attenuates Atherogenesis in Apolipoprotein E-Deficient Mice
por: Du, Fen, et al.
Publicado: (2016)

Tongxinluo promotes axonal plasticity and functional recovery after stroke
por: Wang, Xiaoting, et al.
Publicado: (2020)

Tongxinluo promotes endothelium-dependent arteriogenesis to attenuate diabetic peripheral arterial disease
por: Gu, Jiao-Jiao, et al.
Publicado: (2023)

Effect of transglutaminase 2 (TG2) deficiency on atherosclerotic plaque stability in the apolipoprotein E deficient mouse
por: Williams, Helen, et al.
Publicado: (2010)

The Role of Iron in Atherosclerosis in Apolipoprotein E Deficient Mice
por: Ma, Juan, et al.
Publicado: (2022)

Apolipoprotein E deficiency accelerates atherosclerosis development in miniature pigs
por: Fang, Bin, et al.
Publicado: (2018)

Endothelial Dysfunction in the Apolipoprotein E-deficient Mouse: insights into the influence of diet, gender and aging
por: Meyrelles, Silvana S, et al.
Publicado: (2011)

Aging decreases antioxidant effects and increases lipid peroxidation in the Apolipoprotein E deficient mouse
por: Honma, Taro, et al.
Publicado: (2013)

Effect of Tongxinluo on Nephrin Expression via Inhibition of Notch1/Snail Pathway in Diabetic Rats
por: Cui, Fangqiang, et al.
Publicado: (2015)

Tongxinluo attenuates reperfusion injury in diabetic hearts by angiopoietin-like 4-mediated protection of endothelial barrier integrity via PPAR-α pathway
por: Qi, Kang, et al.
Publicado: (2018)

Influence of Domain Stability on the Properties of Human Apolipoprotein E3 and E4 and Mouse Apolipoprotein E
por: Nguyen, David, et al.
Publicado: (2014)

Continuous Hypobaric Hypoxia may Promote Atherosclerosis Progression in Apolipoprotein E-deficient Mice
por: Luo, Shouming, et al.
Publicado: (2023)

Variation in Type 2 Diabetes-Related Phenotypes among Apolipoprotein E-Deficient Mouse Strains
por: Liu, Shuiping, et al.
Publicado: (2015)

Experimental evidence and network pharmacology-based analysis reveal the molecular mechanism of Tongxinluo capsule administered in coronary heart diseases
por: Li, Guode, et al.
Publicado: (2020)

Traditional Chinese Medicine Tongxinluo Improves Cardiac Function of Rats with Dilated Cardiomyopathy
por: Shen, Fang-Fang, et al.
Publicado: (2014)

Tongxinluo Reverses the Hypoxia-suppressed Claudin-9 in Cardiac Microvascular Endothelial Cells
por: Liu, Kun, et al.
Publicado: (2016)

PEP-1-MsrA ameliorates inflammation and reduces atherosclerosis in apolipoprotein E deficient mice
por: Wu, Yao, et al.
Publicado: (2015)

Effects of tongxinluo on the neointima formation and expression of inflammatory cytokines in rats after carotid artery balloon injury
por: Yao, En-Hui, et al.
Publicado: (2014)

Betaine Supplementation Attenuates S-Adenosylhomocysteine Hydrolase-Deficiency-Accelerated Atherosclerosis in Apolipoprotein E-Deficient Mice
por: Dai, Xin, et al.
Publicado: (2022)

Effect of Tongxinluo on Podocyte Apoptosis via Inhibition of Oxidative Stress and P38 Pathway in Diabetic Rats
por: Cui, Fangqiang, et al.
Publicado: (2016)

Anti-atherogenic effect of Humulus japonicus in apolipoprotein E-deficient mice
por: Lim, Haian, et al.
Publicado: (2016)

Nicotinamide Prevents Apolipoprotein B-Containing Lipoprotein Oxidation, Inflammation and Atherosclerosis in Apolipoprotein E-Deficient Mice
por: Méndez-Lara, Karen Alejandra, et al.
Publicado: (2020)

Systematic Review of Tongxinluo Capsule on the Therapeutic Effect and Hemorheology of Patients with Transient Ischemic Attack
por: Yang, Peng, et al.
Publicado: (2021)

Tongxinluo May Alleviate Inflammation and Improve the Stability of Atherosclerotic Plaques by Changing the Intestinal Flora
por: Qi, Yan, et al.
Publicado: (2022)

TRAIL attenuates the development of atherosclerosis in apolipoprotein E deficient mice
por: Watt, Victoria, et al.
Publicado: (2011)

Visfatin Destabilizes Atherosclerotic Plaques in Apolipoprotein E–Deficient Mice
por: Li, Bo, et al.
Publicado: (2016)

Effects of Dual-Dose Clopidogrel, Clopidogrel Combined with Tongxinluo Capsule, and Ticagrelor on Patients with Coronary Heart Disease and CYP2C19*2 Gene Mutation After Percutaneous Coronary Interventions (PCI)
por: Chen, Shuxia, et al.
Publicado: (2017)

Inhibition of Endoplasmic Reticulum Stress and Atherosclerosis by 2-Aminopurine in Apolipoprotein E-Deficient Mice
por: Zhou, Lichun, et al.
Publicado: (2013)

Apolipoprotein E synthesized by adipocyte and apolipoprotein E carried on lipoproteins modulate adipocyte triglyceride content
por: Li, Yan-hong, et al.
Publicado: (2014)

Osteopontin deficiency reduces kidney damage from hypercholesterolemia in Apolipoprotein E-deficient mice
por: Pei, Zouwei, et al.
Publicado: (2016)

Tongxinluo Improves Cardiac Function and Ameliorates Ventricular Remodeling in Mice Model of Myocardial Infarction through Enhancing Angiogenesis
por: Bai, Wen-Wu, et al.
Publicado: (2013)

P-Selectin or Intercellular Adhesion Molecule (Icam)-1 Deficiency Substantially Protects against Atherosclerosis in Apolipoprotein E–Deficient Mice
por: Collins, Robert G., et al.
Publicado: (2000)

Loss of Caspase‐Activated DNase Protects Against Atherosclerosis in Apolipoprotein E–Deficient Mice
por: Chao, Meng‐Lin, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_65dfgfl4fivdpfmgfg9ldl4o2r